Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Meridian Bioscience Reports Flat Fiscal Q4 Revenues, FY16 Revenues Up 1 Percent

Meridian Bioscience Reports Flat Fiscal Q4 Revenues, FY16 Revenues Up 1 Percent

Nov 10, 2016

NEW YORK (GenomeWeb) – Meridian Bioscience today reported flat fiscal fourth quarter revenues and a 1 percent increase in fiscal year 2016 revenues.

The results were consistent with preliminary earnings announced last month that sent the firm's stock tumbling.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In PCR

  1. LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

  2. Progenity Files for IPO, Seeks to Raise up to $100M

  3. Bio-Me Eyes PCR-Based Microbiome Profiling Technology for Future CDx

    Premium

  4. BioGX, Bosch Healthcare Solutions Partner to Develop Point-of-Care Infectious Disease Tests

  5. FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.